Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Consolidated Net Income (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Consolidated Net Income readings, the most recent being -$104035.0 for Q1 2026.

  • On a quarterly basis, Consolidated Net Income rose 31.42% to -$104035.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$532943.0, a 76.64% decrease, with the full-year FY2025 number at -$557627.0, down 12.17% from a year prior.
  • Consolidated Net Income reached -$104035.0 in Q1 2026 per CBIH's latest filing, down from -$99107.0 in the prior quarter.
  • The five-year high for Consolidated Net Income was $18270.0 in Q2 2024, with the low at -$324655.0 in Q1 2023.
  • A 5-year average of -$152913.5 and a median of -$127871.0 in 2025 define the central range for Consolidated Net Income.
  • Year-over-year, Consolidated Net Income soared 106.62% in 2024 and then crashed 1400.76% in 2025.
  • Year by year, Consolidated Net Income stood at -$219886.0 in 2022, then skyrocketed by 57.02% to -$94512.0 in 2023, then increased by 27.7% to -$68328.0 in 2024, then tumbled by 45.05% to -$99107.0 in 2025, then fell by 4.97% to -$104035.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Consolidated Net Income are -$104035.0 (Q1 2026), -$99107.0 (Q4 2025), and -$92152.0 (Q3 2025).